What is the difference between ACETAMINOPHEN and ZOLMITRIPTAN?

ACETAMINOPHEN is a Analgesic (Non-Opioid) and ZOLMITRIPTAN is a Triptan (Migraine). They reach a similar treatment goal through different pharmacological mechanisms, which is why one may be tolerated by a patient who could not tolerate the other.

Is Pain Reliever Extra Strength the same as Zolmitriptan?

No. Pain Reliever Extra Strength (ACETAMINOPHEN) and Zolmitriptan (ZOLMITRIPTAN) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ACETAMINOPHEN or ZOLMITRIPTAN?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ACETAMINOPHEN to ZOLMITRIPTAN?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ACETAMINOPHEN vs ZOLMITRIPTAN

Compare ACETAMINOPHEN (Pain Reliever Extra Strength) and ZOLMITRIPTAN (Zolmitriptan) — clinical data, side effects, and patient experiences.

ACETAMINOPHEN

Pain Reliever Extra Strength, APADAZ · Analgesic (Non-Opioid)

How it works

Other agent

Approved for

Uses temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

OralTablet

ZOLMITRIPTAN

Zolmitriptan · Triptan (Migraine)

How it works

12.1 Mechanism of Action Zolmitriptan binds with high affinity to human recombinant 5-HT 1D and 5-HT 1B receptors, and moderate affinity for 5-HT 1A receptors. The N-desmethyl meta...

Approved for

See full prescribing information

NasalTablet

Quick Comparison

ACETAMINOPHENZOLMITRIPTAN

Drug Class

Analgesic (Non-Opioid)

Triptan (Migraine)

Route

Oral

Nasal

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACETAMINOPHEN

Drug Not Working

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Joint Pain

1-10%

Vomiting

0.1-1%

ZOLMITRIPTAN

Headache

>10%

Drug Not Working

>10%

Nausea

1-10%

Fatigue

1-10%

Vomiting

0.1-1%

Dizziness

0.1-1%

General Unwellness

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

ACETAMINOPHEN

Warnings Liver warning: This product contains acetaminophen
Stop use and ask a doctor if new symptoms occur pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present These could be signs of a serious condition

ZOLMITRIPTAN

5 WARNINGS AND PRECAUTIONS Myocardial Ischemia, Myocardial Infarction, and Prinzmetal's Angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors (5
2) Chest/throat/neck/jaw pain, tightness, pressure, or heaviness: Generally not associated with myocardial ischemia; evaluate for coronary artery disease in patients at high risk (5
1 Myocardial Ischemia, Myocardial Infarction, and Prinzmetal's Angina Zolmitriptan is contraindicated in patients with ischemic or vasospastic coronary artery disease (CAD)
There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of zolmitriptan

Clinical Trial Data

No head-to-head clinical studies found for ACETAMINOPHEN vs ZOLMITRIPTAN.

ACETAMINOPHEN vs ZOLMITRIPTAN: What You Should Know

Key Differences

ACETAMINOPHEN is a Analgesic (Non-Opioid), while ZOLMITRIPTAN belongs to the Triptan (Migraine) class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. ACETAMINOPHEN is administered via Oral, whereas ZOLMITRIPTAN uses Nasal. Route of administration can affect onset of action and patient adherence.

Safety Considerations

ACETAMINOPHEN carries 2 FDA warnings. ZOLMITRIPTAN carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

FROVATRIPTAN SUCCINATE vs ZOLMITRIPTAN→ELETRIPTAN HBR vs ZOLMITRIPTAN→SUMATRIPTAN SUCCINATE vs ZOLMITRIPTAN→RIZATRIPTAN vs ZOLMITRIPTAN→RIZATRIPTAN BENZOATE ODT vs ZOLMITRIPTAN→ALMOTRIPTAN vs ZOLMITRIPTAN→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ACETAMINOPHEN: DailyMed label · FAERS adverse events · ClinicalTrials.gov
ZOLMITRIPTAN: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ACETAMINOPHEN vs ZOLMITRIPTAN

Compare ACETAMINOPHEN (Pain Reliever Extra Strength) and ZOLMITRIPTAN (Zolmitriptan) — clinical data, side effects, and patient experiences.

ACETAMINOPHEN

Pain Reliever Extra Strength, APADAZ · Analgesic (Non-Opioid)

How it works

Other agent

Approved for

Uses temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

OralTablet

ZOLMITRIPTAN

Zolmitriptan · Triptan (Migraine)

How it works

12.1 Mechanism of Action Zolmitriptan binds with high affinity to human recombinant 5-HT 1D and 5-HT 1B receptors, and moderate affinity for 5-HT 1A receptors. The N-desmethyl meta...

Approved for

See full prescribing information

NasalTablet

Quick Comparison

ACETAMINOPHENZOLMITRIPTAN

Drug Class

Analgesic (Non-Opioid)

Triptan (Migraine)

Route

Oral

Nasal

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACETAMINOPHEN

Drug Not Working

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Joint Pain

1-10%

Vomiting

0.1-1%

ZOLMITRIPTAN

Headache

>10%

Drug Not Working

>10%

Nausea

1-10%

Fatigue

1-10%

Vomiting

0.1-1%

Dizziness

0.1-1%

General Unwellness

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

ACETAMINOPHEN

Warnings Liver warning: This product contains acetaminophen
Stop use and ask a doctor if new symptoms occur pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present These could be signs of a serious condition

ZOLMITRIPTAN

5 WARNINGS AND PRECAUTIONS Myocardial Ischemia, Myocardial Infarction, and Prinzmetal's Angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors (5
2) Chest/throat/neck/jaw pain, tightness, pressure, or heaviness: Generally not associated with myocardial ischemia; evaluate for coronary artery disease in patients at high risk (5
1 Myocardial Ischemia, Myocardial Infarction, and Prinzmetal's Angina Zolmitriptan is contraindicated in patients with ischemic or vasospastic coronary artery disease (CAD)
There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of zolmitriptan

Clinical Trial Data

No head-to-head clinical studies found for ACETAMINOPHEN vs ZOLMITRIPTAN.

ACETAMINOPHEN vs ZOLMITRIPTAN: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.